Second, we uncovered for the first time that CYP19A1 inhibition downregulated PD-L1, IL-6 and TGF-β expression in colon cancer cells, and thereby enhanced the tumor-killing ability of CD8+ T cells. This evidence concerns the gene IL6 and colonic neoplasm.